TOP STORIES
Allergan is the center of attention in a couple of stories this morning. Allergan is acquiring antidepressant drug developer Naurex in a $560 million deal. Allergan CEO Brent Saunders said it was interested in the potential of Naurex’s drug to curb suicide.
“Depression remains one of the largest unmet areas of medical need. When you think about existing therapies, they have modest effects with lots of side effects.” — Forbes
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Meanwhile Teva has agreed to buy Allergan’s generics business in a $40.5 billion deal that’s set to boost the Israeli pharmaceuticals company to big pharma status. — The Wall Street Journal
LIFE SCIENCE
A cholesterol drug developed by Regeneron Pharmaceuticals and Sanofi has secured FDA approval. The FDA has limited its use to patients with a hereditary form of the condition and those with cardiovascular disease. — Reuters
AstraZeneca has agreed to sell its rare disease drug Caprelsa to Genzyme in a $300 million deal. The drug is used to treat aggressive and symptomatic medullary thyroid carcinoma. — AstraZeneca
A Personalized Approach to Medication Nonadherence
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
TECH
The National Institute of Standards and Technology has published a draft guide on how to secure mobile devices for the healthcare industry assembled by industry and academic cybersecurity experts, with the input of health care providers. HIStalk, NIST,
A LITTLE BIT EXTRA
A mobile security expert warned that 95 percent of Google Android phones are vulnerable to being hacked through a multimedia text message. Although Joshua Drake of Zimperium zLabs, reported the bugs in April, he doesn’t think most manufacturers have implemented the fixes through patches sent by Google. — Forbes
Photo: BigStock Photos
